The TLR9 signaling pathway has been reported to promote cardiac inflammation by activating interferon regulatory factor 5 (IRF5) in coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC). The gene discussed is IRF5; the disease is liver mesenchymal hamartoma.